AlphaOne Investment Services’s Myriad Genetics MYGN Stock Holding History

AlphaOne Investment Services’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-11,954	Closed	-$326K	–	75
2019 Q4	$326K	Buy	11,954 +2,185	+22%	+$60.1K	0.54%	46
2019 Q3	$280K	Sell	9,769 -22	-0.2%	-$641	0.46%	41
2019 Q2	$272K	Buy	9,791 +9,012	+1,157%	+$255K	0.21%	103
2019 Q1	$26K	Buy	779 +150	+24%	+$4.57K	0.02%	156
2018 Q4	$18K	Buy	629 +29	+5%	+$1.04K	0.01%	174
2018 Q3	$28K	Hold	600	–	–	0.01%	167
2018 Q2	$22K	Buy	+600	New	+$20.3K	0.01%	186

Other funds holding MYGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

AlphaOne Investment Services's MYGN Position: Q1 2020 in Review

AlphaOne Investment Services sold out of Myriad Genetics (MYGN) in Q1 2020, closing a stake of 11,954 shares — an estimated $326K sold.

AlphaOne Investment Services first reported a position in MYGN in Q2 2018 and held it in 7 quarters. The position peaked at $326K in Q4 2019. 189 funds tracked by Wall St. Rank hold MYGN as of Q1 2020.

AlphaOne Investment Services reported no remaining Myriad Genetics position as of Q1 2020 after selling out during the quarter.
AlphaOne Investment Services sold 11,954 Myriad Genetics shares in Q1 2020, an estimated $326K.
AlphaOne Investment Services first reported a position in Myriad Genetics in Q2 2018 and held it in 7 quarters.
AlphaOne Investment Services's Myriad Genetics position peaked at $326K in Q4 2019.
189 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2020.

Based on AlphaOne Investment Services's 13F filing for Q1 2020, filed 14 May 2020.